Rajesh Singh

7.9k total citations · 4 hit papers
98 papers, 5.7k citations indexed

About

Rajesh Singh is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Rajesh Singh has authored 98 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 30 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Rajesh Singh's work include Chemokine receptors and signaling (24 papers), Immunotherapy and Immune Responses (13 papers) and Cancer Mechanisms and Therapy (10 papers). Rajesh Singh is often cited by papers focused on Chemokine receptors and signaling (24 papers), Immunotherapy and Immune Responses (13 papers) and Cancer Mechanisms and Therapy (10 papers). Rajesh Singh collaborates with scholars based in United States, India and Nepal. Rajesh Singh's co-authors include James W. Lillard, Santosh Kumar Singh, Shriti Singh, Varma Saikam, Shailesh Singh, Indrajit Chowdhury, Manoj K. Mishra, Udai P. Singh, Edward P. Acosta and Saswati Banerjee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Rajesh Singh

93 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle-based targeted drug delivery

2009 2.0k citations Rajesh Singh, James W. Lillard profile →
Challenges in liver cancer and possible treatment approaches

2019 1.0k citations Santosh Kumar Singh, Shriti Singh et al. profile →
Understanding the Mechanism of Bacterial Biofilms Resistance to Antimicrobial Agents

2017 507 citations Shriti Singh, Santosh Kumar Singh et al. profile →
Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer

2023 83 citations Santosh Kumar Singh, Gabriela Oprea‐Ilies et al. Cancers profile →

Peers

Rajesh Singh

MB

BIOMA

ONCOL

BE

IMMUN

James W. Lillard United States

Jagat R. Kanwar Australia

Meena Jaggi United States

Song Li United States

Subhash C. Chauhan United States

M. Guillaume Wientjes United States

Mandip Singh United States

Jae‐Young Lee South Korea

Xian Qi China

Agnese Molinari Italy

James W. Lillard United States

Rajesh Singh

2.0k ×0.9

MB

1.1k ×0.9

BIOMA

1.3k ×1.3

ONCOL

789 ×0.8

BE

1.6k ×1.9

IMMUN

Citations per year, relative to Rajesh Singh Rajesh Singh (= 1×) peers James W. Lillard

Countries citing papers authored by Rajesh Singh

Since Specialization

Citations

This map shows the geographic impact of Rajesh Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Singh more than expected).

Fields of papers citing papers by Rajesh Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Singh. The network helps show where Rajesh Singh may publish in the future.

Co-authorship network of co-authors of Rajesh Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Singh. A scholar is included among the top collaborators of Rajesh Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Singh. Rajesh Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Singh, Rajesh, et al.. (2024). Nanodiamonds: Next generation nano-theranostics for cancer therapy. Cancer Letters. 587. 216710–216710. 16 indexed citations

2.

Mir, Hina, et al.. (2024). Social and Biological Determinants in Lung Cancer Disparity. Cancers. 16(3). 612–612. 13 indexed citations

3.

Chandrashekar, Darshan S., Farrukh Afaq, Santhosh Kumar Karthikeyan, et al.. (2024). Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells. Neoplasia. 57. 101046–101046. 2 indexed citations

4.

Singh, Santosh Kumar, et al.. (2023). Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers. 15(4). 1320–1320. 83 indexed citations breakdown →

5.

Singh, Shriti, et al.. (2022). Clinical Prediction of Type 2 Diabetes Mellitus (T2DM) via Anthropometric and Biochemical Variations in Prakriti. SHILAP Revista de lepidopterología. 10(1). 15–15. 5 indexed citations

6.

Dammer, Eric B., Fengxia Yan, Sanjay Jain, et al.. (2022). Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. Cancers. 14(9). 2228–2228. 3 indexed citations

7.

Mir, Hina, Neeraj Kapur, Dominique N. Gales, et al.. (2021). CXCR6-CXCL16 Axis Promotes Breast Cancer by Inducing Oncogenic Signaling. Cancers. 13(14). 3568–3568. 12 indexed citations

8.

Singh, Santosh Kumar, Shailesh Singh, & Rajesh Singh. (2021). Targeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia. Journal of Ovarian Research. 14(1). 126–126. 11 indexed citations

9.

Sharma, Prayas, et al.. (2013). Some Exponential Ratio-Product Type Estimators using information on Auxiliary Attributes under Second Order Approximation. 12(3). 58–66. 11 indexed citations

10.

Singh, Rajesh, Shailesh Singh, William E. Grizzle, & James W. Lillard. (2011). CXCL13 and CXCR5 expression by Non-Small Cell Lung Carcinoma (149.15). The Journal of Immunology. 186. 1 indexed citations

11.

Singh, Rajesh, Shailesh Singh, William E. Grizzle, & James W. Lillard. (2011). CXCL13 and CXCR5 expression by Non-Small Cell Lung Carcinoma (149.15). The Journal of Immunology. 186(1_Supplement). 149.15–149.15. 3 indexed citations

12.

Lillard, James W., Rajesh Singh, Praveen Sharma, & Shailesh Singh. (2010). CXCL13 inhibition prevents bone metastasis in hormone-refractory prostate cancer (133.8). The Journal of Immunology. 184(Supplement_1). 133.8–133.8. 6 indexed citations

13.

Patel, Vipul, et al.. (2010). BCR ABL KINASE INHIBITORS FOR CANCER THERAPY. International Journal of Pharmaceutical Sciences and Drug Research. 80–90. 10 indexed citations

14.

Sikand, Kavleen, et al.. (2010). miR 488* inhibits androgen receptor expression in prostate carcinoma cells. International Journal of Cancer. 129(4). 810–819. 104 indexed citations

15.

Singh, Rajesh, et al.. (2009). CXCL11 and CXCL12 activates ERK1/2 and NF-kB in breast cancer cells via CXCR3, CXCR4 and CXCR7 (98.3). The Journal of Immunology. 182(Supplement_1). 98.3–98.3. 1 indexed citations

16.

El-Haibi, Christelle P, Rajesh Singh, Praveen Sharma, Shailesh Singh, & James W. Lillard. (2009). CXCL13 blockade abrogates bone metastasis by impairing beta-3 integrin activation and matrix metalloproteinase expression by prostate cancer cells (98.4). The Journal of Immunology. 182(Supplement_1). 98.4–98.4. 1 indexed citations

17.

Singh, Udai P., Shailesh Singh, Rajesh Singh, et al.. (2008). CXCL10-Producing Mucosal CD4 ⁺ T Cells, NK Cells, and NKT Cells Are Associated with Chronic Colitis in IL-10 ^−/− Mice, Which Can Be Abrogated by Anti-CXCL10 Antibody Inhibition. Journal of Interferon & Cytokine Research. 28(1). 31–43. 45 indexed citations

18.

Singh, Udai P., Rajesh Singh, Shailesh Singh, et al.. (2008). CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. BMC Immunology. 9(1). 25–25. 26 indexed citations

19.

Palaniappan, Ravichandran, Shailesh Singh, Udai P. Singh, et al.. (2006). CCL5 Modulates Pneumococcal Immunity and Carriage. The Journal of Immunology. 176(4). 2346–2356. 33 indexed citations

20.

Singh, Shailesh, Rajesh Singh, Udai P. Singh, et al.. (2006). CXCR5-CXCL13 expression regulates cellular mechanisms involved in prostate cancer cell invasion and correlates with prostate cancer progression. Cancer Research. 66. 68–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact